These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 31195850

  • 1. Brivaracetam efficacy and safety in focal epilepsy.
    Makke Y, Abou-Khalil B.
    Expert Rev Neurother; 2019 Oct; 19(10):955-964. PubMed ID: 31195850
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC, Geldard J, Peacey C, Wright E, Eltayeb K, Maguire M.
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [Abstract] [Full Text] [Related]

  • 3. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
    Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A.
    Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
    [Abstract] [Full Text] [Related]

  • 4. Brivaracetam in the treatment of epilepsy: a review of clinical trial data.
    Feyissa AM.
    Neuropsychiatr Dis Treat; 2019 Jul; 15():2587-2600. PubMed ID: 31571877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT, Gagné J, Wolf DC, Aboulamer S, Bosoi CM, Simard A, Messiet E, Desgent S, Carmant L.
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B.
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation.
    Adewusi J, Burness C, Ellawela S, Emsley H, Hughes R, Lawthom C, Maguire M, McLean B, Mohanraj R, Oto M, Singhal S, Reuber M.
    Epilepsy Behav; 2020 May; 106():106967. PubMed ID: 32179501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA, Sperling MR, Chung S, Klein P, Diaz A, Elmoufti S, Schiemann J, Whitesides J.
    Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
    [Abstract] [Full Text] [Related]

  • 17. An update on brivaracetam for the treatment of pediatric partial epilepsy.
    Tulli E, Di Cara G, Iapadre G, Striano P, Verrotti A.
    Expert Opin Pharmacother; 2021 Aug; 22(11):1387-1395. PubMed ID: 33896317
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents.
    Schubert-Bast S, Willems LM, Kurlemann G, Knake S, Müller-Schlüter K, Rosenow F, Strzelczyk A.
    Epilepsy Behav; 2018 Dec; 89():89-93. PubMed ID: 30390435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.